Oramed Pharmaceuticals Inc (ORMP)
Oramed Pharmaceuticals is a pharmaceutical company. Co. is engaged in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. Co.'s primary product, ORMD-0801, is an orally ingestible insulin capsule for the treatment of diabetes. In addition to its key product, the ORMD-0801 insulin capsule, Co. is using its technology for an orally ingestible Glucagon-like peptide-1 capsule, or ORMD-0901. Co. is developing a drug candidate, a weight loss treatment in the form of an oral leptin capsule.
Company Name: |
Oramed Pharmaceuticals Inc |
Website: |
www.oramed.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding ORMP: |
3 |
Total Market Value Held by ETFs: |
$323285 |
Total Market Capitalization: |
$96.00M |
% of Market Cap. Held by ETFs: |
0.34% |
|
|
April 29, 2024 3:28 AM Eastern
Hold (2.00 out of 4)
0th percentile
|
|